Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Insulin9623 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A38336 | 11513189 | Am J Gastroenterol | Hyperferritinemia, iron overload, and multiple metabolic alterations identify patients at risk for nonalcoholic steatohepatitis. | 2001 | Details |
| A38338 | 11501194 | Clin Cornerstone | Fatty liver and nonalcoholic steatohepatitis. | 2001 | Details |
| A38395 | 11349722 | Transplantation | Lipoatrophic diabetes and end-stage liver disease secondary to nonalcoholic steatohepatitis with recurrence after liver transplantation. | 2001 | Details |
| A38417 | 11296694 | Semin Liver Dis | Etiopathogenesis of nonalcoholic steatohepatitis. | 2001 | Details |
| A38431 | 11266382 | Gastroenterology | Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. | 2001 | Details |
| A38442 | 11232700 | Am J Gastroenterol | A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis. | 2001 | Details |
| A38466 | 11169153 | Pathol Int | Hepatocellular carcinoma arising in non-alcoholic steatohepatitis. | 2001 | Details |
| A38476 | 11151896 | Am J Gastroenterol | Serum leptin levels in patients with nonalcoholic steatohepatitis. | 2000 | Details |
| A38606 | 10799085 | Can J Gastroenterol | Nonalcoholic steatohepatitis: an evolving diagnosis. | 2000 | Details |
| A38659 | 10634920 | Clin Nutr | Non-alcoholic fatty liver: another feature of the metabolic syndrome? | 1999 | Details |
| A38697 | 10545713 | Dig Dis | Fatty liver and nonalcoholic steatohepatitis. Where do we stand and where are we going? | 1999 | Details |
| A38701 | 10535879 | Gastroenterology | Insulin resistance-associated hepatic iron overload. | 1999 | Details |
| A38705 | 10522010 | Hepatogastroenterology | Leptin levels in nonalcoholic steatohepatitis and chronic hepatitis C. | 1999 | Details |
| A42220 | 35182734 | Drug Discov Today | Mechanisms of antidiabetic drugs and cholesterol efflux: A clinical perspective. | 2022 | Details |
| A42234 | 35146047 | Open Forum Infect Dis | Metabolic-Associated Fatty Liver Disease Is Highly Prevalent in the Postacute COVID Syndrome. | 2022 | Details |
| A42236 | 35127953 | J Diabetes Res | Metabolic (Dysfunction)-Associated Fatty Liver Disease in Chinese Patients with Type 2 Diabetes from a Subcenter of the National Metabolic Management Center. | 2022 | Details |
| A42243 | 35115401 | Proc Natl Acad Sci U S A | Cullin neddylation inhibitor attenuates hyperglycemia by enhancing hepatic insulin signaling through insulin receptor substrate stabilization. | 2022 | Details |
| A42246 | 35106852 | Phytother Res | A systematic review and meta-analysis of preclinical and clinical studies on the efficacy of ginger for the treatment of fatty liver disease. | 2022 | Details |
| A42261 | 35047117 | World J Diabetes | Omics era in type 2 diabetes: From childhood to adulthood. | 2021 | Details |
| A42263 | 35046902 | Front Endocrinol (Lausanne) | Molecular and Cellular Bases of Lipodystrophy Syndromes. | 2022 | Details |
| A42274 | 35022960 | Mol Cell Biochem | Autophagy: a molecular switch to regulate adipogenesis and lipolysis. | 2022 | Details |
| A42286 | 34981780 | J Clin Invest | Do endocannabinoids acting via hepatic CB-1 contribute to NAFLD and hepatic insulin resistance? | 2022 | Details |
| A42287 | 34979132 | J Hepatol | Metabolic and genetic contributions to NAFLD: Really distinct and homogeneous? | 2021 | Details |
| A42291 | 34957482 | Diabetes | Hepatic P38 Activation Modulates Systemic Metabolism Through Fgf21-Mediated Interorgan Communication. | 2021 | Details |
| A42320 | 34876963 | Oxid Med Cell Longev | Early-Life Exposure to Low-Dose Cadmium Accelerates Diethylnitrosamine and Diet-Induced Liver Cancer. | 2021 | Details |
| A42332 | 34847647 | Diabetes Metab J | Albuminuria Is Associated with Steatosis Burden in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease (Diabetes Metab J 2021;45:698-707). | 2021 | Details |
| A42333 | 34847645 | Diabetes Metab J | Albuminuria Is Associated with Steatosis Burden in Patients with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease (Diabetes Metab J 2021;45:698-707). | 2021 | Details |
| A42337 | 34825869 | Curr Drug Metab | Regulatory Effects of N-3 PUFAs on Pancreatic β-cells and Insulin-sensitive Tissues. | 2021 | Details |
| A42359 | 34767670 | Biofactors | Vitamin D3 enhances the effects of omega-3 oils against metabolic dysfunction-associated fatty liver disease in rat. | 2021 | Details |
| A42389 | 34698347 | Clin Infect Dis | Evolution of Fatty Liver Disease and Relationship With Lipoproteins and Clinical Outcomes in Hepatitis B/Human Immunodeficiency Virus Coinfection. | 2022 | Details |
| A42390 | 34697893 | J Dig Dis | Multidisciplinary participation: The key to a cure for non-alcoholic fatty liver disease. | 2021 | Details |
| A42392 | 34689140 | Horm Res Paediatr | Genetic Obesity in Children: Overview of Possible Diagnoses with a Focus on SH2B1 Deletion. | 2021 | Details |
| A42395 | 34675006 | Diabetes | Hepatic P38 Activation Modulates Systemic Metabolism Through Fgf21-Mediated Interorgan Communication. | 2021 | Details |
| A42406 | 34621322 | Evid Based Complement Alternat Med | YiQi YangYin Decoction Attenuates Nonalcoholic Fatty Liver Disease in Type 2 Diabetes Rats. | 2021 | Details |
| A42407 | 34618686 | J Clin Invest | Inhibiting serotonin signaling through HTR2B in visceral adipose tissue improves obesity-related insulin resistance. | 2021 | Details |
| A42421 | 34572340 | Biomedicines | Short-Term SGLT2 Inhibitor Administration Does Not Alter Systemic Insulin Clearance in Type 2 Diabetes. | 2021 | Details |
| A42422 | 34572325 | Biomedicines | Glycomacropeptide for Management of Insulin Resistance and Liver Metabolic Perturbations. | 2021 | Details |
| A42423 | 34564583 | Vet Sci | Imipramine Accelerates Nonalcoholic Fatty Liver Disease, Renal Impairment, Diabetic Retinopathy, Insulin Resistance, and Urinary Chromium Loss in Obese Mice. | 2021 | Details |
| A42430 | 34542351 | Crit Rev Food Sci Nutr | Branched chain amino acids-friend or foe in the control of energy substrate turnover and insulin sensitivity? | 2021 | Details |
| A42441 | 34511811 | J Clin Exp Hepatol | Lean Fatty Liver Disease: Through Thick and Thin. | 2021 | Details |
| A42452 | 34503598 | J Dev Orig Health Dis | Metabolic programming in offspring of mice fed fructose during pregnancy and lactation. | 2021 | Details |
| A42462 | 34474907 | Am J Cardiol | Independent Association of Fatty Liver Index With Left Ventricular Diastolic Dysfunction in Subjects Without Medication. | 2021 | Details |
| A42469 | 34455076 | Pharmacol Res | The pivotal role of Nrf2 activators in adipocyte biology. | 2021 | Details |
| A42470 | 34449134 | Obesity (Silver Spring) | Salmon peptides limit obesity-associated metabolic disorders by modulating a gut-liver axis in vitamin D-deficient mice. | 2021 | Details |
| A42476 | 34439969 | Biology (Basel) | Aldehyde Dehydrogenase Mutation Exacerbated High-Fat-Diet-Induced Nonalcoholic Fatty Liver Disease with Gut Microbiota Remodeling in Male Mice. | 2021 | Details |
| A42480 | 34425095 | Gastroenterology | Hepatic miR-144 Drives Fumarase Activity Preventing NRF2 Activation During Obesity. | 2021 | Details |
| A42487 | 34402268 | Zhongguo Zhong Yao Za Zhi | [Efficacy and mechanism of new resource medicinal materia Moringa oleifera leaves against hyperlipidemia]. | 2021 | Details |
| A42502 | 34358837 | Clin Nutr | Copper deficiency and nonalcoholic fatty liver disease: The chicken or the egg? | 2021 | Details |
| A42503 | 34358825 | Clin Nutr | Effect of supplementation with calcitriol versus cholecalciferol on insulin resistance in patients with nonalcoholic fatty liver disease: Several issues of concern. | 2021 | Details |
| A42537 | 34221921 | J Clin Transl Hepatol | Efficacy of Intragastric Balloons in the Markers of Metabolic Dysfunction-associated Fatty Liver Disease: Results from Meta-analyses. | 2021 | Details |
| A42547 | 34185279 | Front Med | Low-carbohydrate diets lead to greater weight loss and better glucose homeostasis than exercise: a randomized clinical trial. | 2021 | Details |
| A42553 | 34172646 | Transplantation | Management of Diabetes in Candidates for Liver Transplantation and in Transplant Recipients. | 2022 | Details |
| A42559 | 34163039 | Nat Rev Endocrinol | Therapeutic opportunities for pancreatic β-cell ER stress in diabetes mellitus. | 2021 | Details |
| A42566 | 34153303 | Metabolism | Irisin in nonalcoholic fatty liver disease: Need for an updated meta-analysis. | 2021 | Details |
| A42568 | 34146880 | Chemosphere | Hepatotoxicity in carp (Cyprinus carpio) exposed to environmental levels of norfloxacin (NOR): Some latest evidences from transcriptomics analysis, biochemical parameters and histopathological changes. | 2021 | Details |
| A42574 | 34133256 | Expert Rev Mol Diagn | Dysregulation of lncRNA-H19 in cardiometabolic diseases and the molecular mechanism involved : a systematic review. | 2021 | Details |
| A42577 | 34125228 | J Clin Endocrinol Metab | Endocrine Dysfunction in Patients With Myotonic Dystrophy. | 2021 | Details |
| A42582 | 34114549 | Dtsch Arztebl Int | Possible Mechanisms: Hyperinsulinemia and Endocrine Disrupting Chemicals. | 2021 | Details |
| A42592 | 34082043 | Biochimie | Roles of microRNAs in carbohydrate and lipid metabolism disorders and their therapeutic potential. | 2021 | Details |
| A42611 | 34023388 | J Biol Chem | Inducible hepatic expression of CREBH mitigates diet-induced obesity, insulin resistance, and hepatic steatosis in mice. | 2021 | Details |
| A42614 | 34015974 | Expert Rev Clin Pharmacol | Update on the effects of GLP-1 receptor agonists for the treatment of polycystic ovary syndrome. | 2021 | Details |
| A42617 | 34011630 | Sci Transl Med | ABCB10 exports mitochondrial biliverdin, driving metabolic maladaptation in obesity. | 2021 | Details |
| A42634 | 33953469 | Proc (Bayl Univ Med Cent) | Persistent lactic acidosis in the Mauriac syndrome in type 1 diabetes mellitus. | 2021 | Details |
| A42640 | 33930552 | Clin Gastroenterol Hepatol | Weight Change and the Development of Nonalcoholic Fatty Liver Disease in Metabolically Healthy Overweight Individuals. | 2021 | Details |
| A42654 | 33869980 | J Endocr Soc | Removal of Epididymal Visceral Adipose Tissue Prevents Obesity-Induced Multi-organ Insulin Resistance in Male Mice. | 2021 | Details |
| A42665 | 33856174 | Am Fam Physician | NAFLD in Children and Adolescents. | 2021 | Details |
| A42666 | 33849008 | J Innate Immun | Innate Immune Cells in the Adipose Tissue in Health and Metabolic Disease. | 2021 | Details |
| A42677 | 33819416 | J Pediatr Endocrinol Metab | Prevalence of elevated liver enzymes and their association with type 2 diabetes risk factors in children. | 2021 | Details |
| A42680 | 33809508 | Pharmaceuticals (Basel) | Doxepin Exacerbates Renal Damage, Glucose Intolerance, Nonalcoholic Fatty Liver Disease, and Urinary Chromium Loss in Obese Mice. | 2021 | Details |
| A42690 | 33759592 | Angiology | AST to ALT Ratio and Peripheral Arterial Disease in a Hypertensive Population-Is There a Link? | 2021 | Details |
| A42703 | 33717101 | Front Immunol | Natural Killer Cells: Friend or Foe in Metabolic Diseases? | 2021 | Details |
| A42704 | 33712438 | Gut | NAFLD in lean individuals: not a benign disease. | 2021 | Details |
| A42708 | 33682953 | Nutr Clin Pract | Endogenous Glucose Production in Critical Illness. | 2021 | Details |
| A42709 | 33682344 | FEBS J | Metabolic roles of G protein-coupled receptor signaling in obesity and type 2 diabetes. | 2021 | Details |
| A42726 | 33638026 | Mol Cell Biochem | Endoplasmic reticulum stress and autophagy are involved in adipocyte-induced fibrosis in hepatic stellate cells. | 2021 | Details |
| A42736 | 33604315 | J Hepatocell Carcinoma | Mechanisms Underlying Hepatocellular Carcinoma Progression in Patients with Type 2 Diabetes. | 2021 | Details |
| A42742 | 33596631 | J Biol Regul Homeost Agents | Vitamin D3 supplementation in controlling metabolic changes associated with non-alcoholic steatohepatitis. | 2021 | Details |
| A42748 | 33586679 | J Clin Invest | Muscle Krüppel-like factor 15 regulates lipid flux and systemic metabolic homeostasis. | 2021 | Details |
| A42749 | 33586126 | Am J Clin Dermatol | Psoriasis in Patients with Metabolic Syndrome or Type 2 Diabetes Mellitus: Treatment Challenges. | 2021 | Details |
| A42755 | 33568795 | Nat Rev Gastroenterol Hepatol | The role of farnesoid X receptor in metabolic diseases, and gastrointestinal and liver cancer. | 2021 | Details |
| A42758 | 33561215 | J Nutr | Associations of Serum Fatty Acid Proportions with Obesity, Insulin Resistance, Blood Pressure, and Fatty Liver: The Cardiovascular Risk in Young Finns Study. | 2021 | Details |
| A42770 | 33525643 | Nutrients | The Marine Microalga, Tisochrysis lutea, Protects against Metabolic Disorders Associated with Metabolic Syndrome and Obesity. | 2021 | Details |
| A42776 | 33508742 | Redox Biol | Long non-coding RNA Meg3 deficiency impairs glucose homeostasis and insulin signaling by inducing cellular senescence of hepatic endothelium in obesity. | 2021 | Details |
| A42778 | 33500723 | Theranostics | Activation of N-methyl-D-aspartate receptor regulates insulin sensitivity and lipid metabolism. | 2021 | Details |
| A42780 | 33497712 | Metabolism | Role of the gut microbiota in type 2 diabetes and related diseases. | 2021 | Details |
| A42789 | 33471689 | Endocr Pract | Role of Androgen in Liver Fat Content in Women: Metabolically Advantageous or Disadvantageous? | 2020 | Details |
| A42802 | 33441256 | Clin Res Hepatol Gastroenterol | Association between gut permeability and insulin resistance: Any role for zonulin in patients with non-alcoholic fatty liver disease? | 2021 | Details |
| A42813 | 33378945 | Biomed Pharmacother | A novel quantitative assay for analysis of GLUT4 translocation using high content screening. | 2020 | Details |
| A42819 | 33353459 | Thyroid | Increased Hepatic Fat Content in Patients with Resistance to Thyroid Hormone Beta. | 2021 | Details |
| A42824 | 33346689 | Physiol Genomics | Cell-free DNA and RNA-measurement and applications in clinical diagnostics with focus on metabolic disorders. | 2020 | Details |
| A42837 | 33337585 | Ultrasound Q | Liver Stiffness Is Increased in Polycystic Ovary Syndrome and Related With Complement C1q/Tumor Necrosis Factor-Related Protein 3 Levels: A Point Shear Wave Elastography Study. | 2020 | Details |
| A42858 | 33277657 | J Clin Endocrinol Metab | Elevated Circulating Glutamate Is Associated With Subclinical Atherosclerosis Independently of Established Risk Markers: A Cross-Sectional Study. | 2021 | Details |
| A42863 | 33259630 | Toxicol Sci | Gestational Cd Exposure in the CD-1 Mouse Induces Sex-Specific Hepatic Insulin Insensitivity, Obesity, and Metabolic Syndrome in Adult Female Offspring. | 2020 | Details |
| A42896 | 33164861 | Metabolism | Commentary: Nonalcoholic or metabolic dysfunction-associated fatty liver disease? The epidemic of the 21st century in search of the most appropriate name. | 2020 | Details |
| A42908 | 33142057 | J Med Chem | A Novel N-Substituted Valine Derivative with Unique Peroxisome Proliferator-Activated Receptor γ Binding Properties and Biological Activities. | 2020 | Details |
| A42912 | 33123088 | Front Endocrinol (Lausanne) | The Impact of Adipose Tissue-Derived miRNAs in Metabolic Syndrome, Obesity, and Cancer. | 2020 | Details |
| A42913 | 33117357 | Front Immunol | Role of the Nuclear Receptor Corepressor 1 (NCOR1) in Atherosclerosis and Associated Immunometabolic Diseases. | 2020 | Details |
| A42929 | 33053354 | Cell Rep | Prostaglandin E2-EP4 Axis Promotes Lipolysis and Fibrosis in Adipose Tissue Leading to Ectopic Fat Deposition and Insulin Resistance. | 2020 | Details |
| A42968 | 32930521 | Liver Int | MAFLD vs NAFLD: Let the contest begin! | 2020 | Details |
| A42969 | 32930093 | Elife | SWELL1 regulates skeletal muscle cell size, intracellular signaling, adiposity and glucose metabolism. | 2020 | Details |